Literature DB >> 9100623

Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia.

W P Soutter1, A de Barros Lopes, A Fletcher, J M Monaghan, I D Duncan, E Paraskevaidis, H C Kitchener.   

Abstract

BACKGROUND: Conservative outpatient therapy for cervical intraepithelial neoplasia (CIN) by ablative or excisional techniques is widely used. The main objective of this treatment is the prevention of invasive cervical cancer. We assessed the rate of invasive disease and the duration of the risk of developing invasive cervical cancer after such treatment.
METHODS: Four UK centres have used life-table methods to analyse the long-term results of conservative treatment of CIN. We combined and updated data from these studies to investigate the rate of invasive disease after treatment and the duration of that risk.
FINDINGS: The data comprised 44 699 woman-years of follow-up, with 2116 women under observation 8 years after treatment. 33 women developed invasive cancer, 14 of whom had microinvasion. The cumulative rate of invasion 8 years after treatment was 5.8 per 1000 women and the rate of invasive cancer during this period was 85 (95% CI 60-119) per 100,000 woman-years. The risk of developing cancer did not change throughout the 8 years of follow-up.
INTERPRETATION: These data show that conservative outpatient therapy in women with CIN reduces the risk of invasive cancer of the cervix by 95% during the first 8 years after treatment. However, even with careful, long-term follow-up, the risk of invasive cervical cancer among these women is about five times greater than that among the general population of women throughout that period. Careful follow-up is essential for at least 10 years after conservative treatment of CIN.

Entities:  

Mesh:

Year:  1997        PMID: 9100623     DOI: 10.1016/s0140-6736(96)08295-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Cervical intraepithelial neoplasia and higher long term risk of cancer.

Authors:  Guglielmo Ronco; Mario Giovanni Sideri; Stefano Ciatto
Journal:  BMJ       Date:  2007-10-24

2.  Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study.

Authors:  Ilkka Kalliala; Ahti Anttila; Eero Pukkala; Pekka Nieminen
Journal:  BMJ       Date:  2005-11-19

3.  Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia.

Authors:  Jeong-Yeol Park; Jaeman Bae; Myong Cheol Lim; So Yi Lim; Dong-Ock Lee; Sokbom Kang; Sang-Yoon Park; Byung-Ho Nam; Sang-Soo Seo
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

4.  Absence of dysplasia in the excised cervix by a loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia.

Authors:  Aeli Ryu; Kyehyun Nam; Sooho Chung; Jeongsik Kim; Haehyeog Lee; Eunsuk Koh; Donghan Bae
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

5.  Prognostic outcomes and risk factors for recurrence after laser vaporization for cervical intraepithelial neoplasia: a single-center retrospective study.

Authors:  Keisuke Kodama; Hideaki Yahata; Kaoru Okugawa; Hiroshi Tomonobe; Nobuko Yasutake; Sachiko Yoshida; Hiroshi Yagi; Masafumi Yasunaga; Tatsuhiro Ohgami; Ichiro Onoyama; Kazuo Asanoma; Emiko Hori; Mototsugu Shimokawa; Kiyoko Kato
Journal:  Int J Clin Oncol       Date:  2021-01-04       Impact factor: 3.402

6.  Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study.

Authors:  Björn Strander; Agneta Andersson-Ellström; Ian Milsom; Pär Sparén
Journal:  BMJ       Date:  2007-10-24

7.  Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study.

Authors:  Joy Melnikow; Colleen McGahan; George F Sawaya; Thomas Ehlen; Andrew Coldman
Journal:  J Natl Cancer Inst       Date:  2009-05-12       Impact factor: 13.506

8.  Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence?

Authors:  Björn Strander; Walter Ryd; Keng-Ling Wallin; Bengt Wärleby; Biying Zheng; Ian Milsom; Baback Gharizadeh; Nader Pourmand; Agneta Andersson-Ellström
Journal:  Eur J Cancer       Date:  2007-07-05       Impact factor: 9.162

9.  Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.

Authors:  Hormuzd A Katki; Mark Schiffman; Philip E Castle; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Tina Raine-Bennett; Julia C Gage; Walter K Kinney
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

10.  Incidence of cervical cancer after several negative smear results by age 50: prospective observational study.

Authors:  Matejka Rebolj; Marjolein van Ballegooijen; Elsebeth Lynge; Caspar Looman; Marie-Louise Essink-Bot; Rob Boer; Dik Habbema
Journal:  BMJ       Date:  2009-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.